Details for Patent: 9,295,657
✉ Email this page to a colleague
Which drugs does patent 9,295,657 protect, and when does it expire?
Patent 9,295,657 protects ADRENALIN and is included in two NDAs.
This patent has seven patent family members in seven countries.
Summary for Patent: 9,295,657
Title: | Epinephrine formulations |
Abstract: | Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent. |
Inventor(s): | Kannan; Vinayagam (Rochester, MI), Irish; Patrick (Sterling Heights, MI), Bergren; Michael (Henderson, NV) |
Assignee: | Par Pharmaceutical, Inc. (Chestnut Ridge, NY) |
Application Number: | 14/818,121 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,295,657 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,295,657
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Par Sterile Products | ADRENALIN | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 204200-001 | Dec 7, 2012 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | EMERGENCY TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS | ⤷ Try a Trial | ||||
Par Sterile Products | ADRENALIN | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 204640-001 | Dec 18, 2013 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | EMERGENCY TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,295,657
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2016233682 | ⤷ Try a Trial | |||
Canada | 2978464 | ⤷ Try a Trial | |||
China | 107614017 | ⤷ Try a Trial | |||
European Patent Office | 3268045 | ⤷ Try a Trial | |||
Japan | 2018507915 | ⤷ Try a Trial | |||
South Korea | 20180034307 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |